Dun & Bradstreet Unveils D&B Healthcare Insights to Help Sales and Marketing Teams Across Industries Unlock Opportunities in the Healthcare Ecosystem

31.07.25 14:05 Uhr

Werte in diesem Artikel
Aktien

7,80 EUR -0,10 EUR -1,27%

D&B Healthcare Insights, Available as an Add-On to D&B Hoovers, Elevates Sales & Marketing Strategies to Drive Commercial Success

JACKSONVILLE, Fla., July 31, 2025 /PRNewswire/ -- Dun & Bradstreet (NYSE:DNB), a leading global provider of business data and analytics, today announced the launch of D&B Healthcare Insights, a powerful new dataset designed to help sales and marketing teams uncover growth opportunities and make smarter, faster decisions across the healthcare ecosystem.

D&B Healthcare Insights helps users discover new and useful information about healthcare organizations (HCOs) like hospitals, clinics or health systems and healthcare providers (HCPs). With D&B Hoovers, users gain access to a comprehensive sales and marketing intelligence platform that enables them to build highly targeted lists using healthcare-specific criteria – filtering and organizing data based on attributes tailored to the unique dynamics of the healthcare sector.

"Companies seeking to do business with healthcare organizations need a solution that speaks their language, that captures the full scope of healthcare-specific intelligence, and that connects their specialized offerings to specialized buyers," said Eric Kider, General Manager, Sales & Marketing Solutions at Dun & Bradstreet. "With the launch of D&B Healthcare Insights, we are putting healthcare first—delivering impactful intelligence that enables our clients to unlock new growth opportunities and forge stronger, more strategic relationships across the healthcare landscape. Backed by our scale and deep expertise, we're providing access to one of the most comprehensive healthcare sector data sets available, strengthening data-driven sales and marketing decisions."

D&B Healthcare Insights provides comprehensive insights beyond firmographic data and can help empower companies in life sciences, financial services, insurance, technology, consulting, logistics and more to better understand, engage and serve healthcare-related entities to drive meaningful conversations and accelerate healthcare customer growth.

Key benefits of D&B Healthcare Insights include the ability to:

  • Improve Targeting and Segmentation - Untangle business relationships to uncover addressable markets, define territories and make data-driven decisions.
     
  • Identify New Opportunities - Easily identify prospects by searching on the criteria that are related to your business, so that you can connect your offerings to specialized buyers.
     
  • Boost Account-Level Intelligence - Explore rich facility profiles containing detailed datapoints specific to healthcare organizations.
     
  • Sharpen Sales Messaging - Get current data on healthcare organizations to allow sales members to have more informed conversations based on the services, capabilities, affiliations, and financials of their prospects.

Dun & Bradstreet delivers comprehensive, thorough and high-quality data by combining D&B Hoovers sales and marketing intelligence on over 320M companies and 485M contacts with healthcare insights on over 260,000 healthcare organizations. This breadth of data offerings allows for search based on criteria like healthcare organization type, accreditations, operating room size, bed counts and more, in addition to detailed datapoints such as top primary specialties, procedure volumes, staffing numbers, and total visits.

Healthcare is the first in a series of new, high-impact datasets Dun & Bradstreet plans to introduce this year by continuing to expand its data capabilities to serve the evolving needs of our clients and the industries they lead.

Dun & Bradstreet also offers fully managed Marketing Services to activate targeted campaigns using the same D&B Healthcare Insights that power D&B Hoovers for companies seeking to turn healthcare insights into action.

To learn more about D&B Healthcare Insights, click here for more information.

About Dun & Bradstreet
Dun & Bradstreet, a leading global provider of business decisioning data and analytics, enables companies around the world to improve their business performance. Dun & Bradstreet's Data Cloud fuels solutions and delivers insights that empower customers to accelerate revenue, lower cost, mitigate risk, and transform their businesses. Since 1841, companies of every size have relied on Dun & Bradstreet to help them manage risk and reveal opportunity.

Dun & Bradstreet (PRNewsfoto/Dun & Bradstreet)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dun--bradstreet-unveils-db-healthcare-insights-to-help-sales-and-marketing-teams-across-industries-unlock-opportunities-in-the-healthcare-ecosystem-302517935.html

SOURCE Dun & Bradstreet

In eigener Sache

Übrigens: Dun Bradstreet und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Dun Bradstreet

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Dun Bradstreet

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Dun & Bradstreet

Wer­bung

Analysen zu Dun & Bradstreet

DatumRatingAnalyst
14.02.2018DunBradstreet OverweightBarclays Capital
13.11.2017DunBradstreet Equal WeightBarclays Capital
10.02.2017DunBradstreet UnderweightBarclays Capital
11.02.2015DunBradstreet BuyStifel, Nicolaus & Co., Inc.
21.01.2015DunBradstreet UnderweightBarclays Capital
DatumRatingAnalyst
14.02.2018DunBradstreet OverweightBarclays Capital
11.02.2015DunBradstreet BuyStifel, Nicolaus & Co., Inc.
22.09.2014DunBradstreet OutperformRobert W. Baird & Co. Incorporated
25.05.2012DunBradstreet overweightBarclays Capital
DatumRatingAnalyst
13.11.2017DunBradstreet Equal WeightBarclays Capital
DatumRatingAnalyst
10.02.2017DunBradstreet UnderweightBarclays Capital
21.01.2015DunBradstreet UnderweightBarclays Capital

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dun & Bradstreet nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen